• Partek® Flow® 4.0 Software Brings More Statistical Power, Visualization, and Speed to NGS Analysis

    January 21, 2015

    Align, Analyze, and Visualize Next Generation Sequencing Data in your Browser

    ,

    ST. LOUIS — 1.21.15 — Partek Incorporated announces the newest release of their popular analysis software, Partek Flow 4.0. With new features including multi-factor mixed model ANOVA, Fisher’s exact test, and additional visualizations, Partek Flow is an ideal analysis solution for researchers performing next generation sequencing (NGS) based studies. Using any internet connected computer, tablet, or smartphone researchers are able to:

  • News of Note: Partek® Flow® 4.0 for NGS Analysis Now Shipping

    January 20, 2015

    Partek Flow 4.0 is now shipping and delivers new analyses, visualizations, and features that reveal the biological meaning of your RNA-Seq data quicker and easier than ever before. We’re pretty excited about these features and think you will be too. Take a peek.

  • Recent Publications: Selected List

    January 20, 2015

    Researchers around the world are using Partek software to make biological discoveries. To date, approximately 3,000 peer-reviewed articles using Partek software have been published.

    RNA-Seq

  • RNA-Seq Analysis Pipeline for Ion Torrent™ Data

    January 20, 2015

    Do you have RNA sequencing data from an Ion Torrent machine?

  • Partek® Genomics Suite® Now Supports 64-bit Mac OS X Mavericks

    January 20, 2015

    We’re pleased to announce that Partek Genomics Suite now supports operating systems that use 64-bit functionality such as Mac OS X Mavericks and Yosemite.

  • Researchers at Queen’s University of Belfast Use Partek Software in First Steps Toward Therapies for Chronic Kidney Disease

    January 18, 2015

    Large, genome-wide quantitative evaluation of DNA methylation associated with chronic kidney disease (CKD) reveals several genes with strong biological evidence for differential methylation. RNA-Seq analysis was performed using Partek® Flow® and Partek® Genomics Suite® to confirm the functional role of differential methylation in ELMO1 and PRKAG2. Findings were validated by functional enrichment using Partek® Pathway™. These results could be the first step toward identifying epigenetic therapies for CKD. 

  • Kennedy Krieger Institute and Partek Awarded $1.8M NIH Grant

    February 3, 2014

    Partek Incorporated, in collaboration with the Kennedy Krieger Institute, has been awarded a phase II Small Business Innovation Research (SBIR) grant in the amount of $1.8M by the National Institutes of Health (NIH) to develop commercial software which will analyze human genetic changes and illuminate chromosomal abnormalities underlying conditions such as autism spectrum disorder (ASD), bipolar disorder, and schizophrenia. 

  • Recent Webinar Recordings

    February 3, 2014


    Take a look at these recordings to see how Partek software can help in your research. 

  • Updates in Partek Software

    February 3, 2014


    Partek software supports all microarray, next generation sequencing, and qPCR platforms. Regardless of which data you are analyzing, our software will take your study from start to finish. Here are some of the latest additions to our software tools.

  • Tech Tip: Recommended Aligners by Application

    February 3, 2014


    If you've ever wondered what aligner to use for your application, then download this handy guide compiled by our technical experts. Download now.

Pages